TP53 and cancer: Due to the role of the E1b-55K protein in the inhibition of p53 [2]–[4], selectivity was first thought to be due primarily to inactivating mutations or deletions of the p53 gene in cancer cells, thus relieving the requirement for E1b-55K in virus replication [5]–[8].